ARCHIVES

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

In Brief: Simone, LoBuglio Lead AACI; AMA Honors B.J. Kennedy; FDA Meet Patient Advocates

July 31, 1992

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995

Special Issue: Broder Resigns NCI To Take Job With Drug Company IVAX

December 22, 1994

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013